Molecular and Cellular Analysis of Breast Cancer
Sponsor: Stanford University
This observational or N/A phase trial investigates Breast - Female and Breast - Male and is currently completed. Stanford University leads this study, which shows 17 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
17 versions recorded-
Dec 2025 — Present [monthly]
Completed
Status: Suspended → Completed
-
Jan 2025 — Dec 2025 [monthly]
Suspended
-
Sep 2024 — Jan 2025 [monthly]
Suspended
-
Jul 2024 — Sep 2024 [monthly]
Suspended
-
Mar 2023 — Jul 2024 [monthly]
Suspended
▶ Show 12 earlier versions
-
Mar 2022 — Mar 2023 [monthly]
Suspended
-
Dec 2021 — Mar 2022 [monthly]
Suspended
-
Jan 2021 — Dec 2021 [monthly]
Suspended
-
Nov 2020 — Jan 2021 [monthly]
Suspended
Status: Recruiting → Suspended
-
Aug 2020 — Nov 2020 [monthly]
Recruiting
-
May 2020 — Aug 2020 [monthly]
Recruiting
-
Mar 2019 — May 2020 [monthly]
Recruiting
-
Jun 2018 — Mar 2019 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
Sep 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .